Welcome to a new-look newsletter, highlighting the launch of the new Antimicrobial Copper brand. In this issue, we cover details of the branding, its accompanying global website and the continuing European rollout. We also offer news of clinical trial results from a Department of Defense-funded project in the United States and a Chilean hospital that back up the Selly Oak data.
|
| Introducing The Most Effective Antimicrobial Surface
|
|
Antimicrobial Copper brand
Antimicrobial Copper logo  |
The brand is supported by a new website, www.antimicrobialcopper.com. Content from the Copper Development Association site, including supplier and product
directories, will be migrated to this site in due course.
If you are a supplier and are interested in using the brand, please contact bryony.samuel@copperdev.co.uk.
For more information, please see the accompanying press release or the Antimicrobial Copper brand brochure.
|
Brand Launch Events
|
|
Global brand rollout
The Antimicrobial Copper brand roll out in Europe follows the official launch in the US in March at the Fifth Decennial International Conference on
Healthcare-Associated Infections in Atlanta. Following the UK launch, further events are planned throughout Europe, with the next one being the Hôpital Expo 2010 in France, taking place from May 18th to the 21st. CICLA, the French Copper Centre, will be exhibiting at this event and promoting the Antimicrobial Copper brand. |
| Trials in US and Chile Confirm UK Results
|
|
ICU copper touch surfaces show less contamination
Confirming the Selly Oak clinical trial results, a 3-centre, Department of Defense-funded study has shown that contamination is significantly reduced on copper surfaces compared to non-copper items.
Copper bed rails, tray tables, chair arms, call buttons, monitors and IV poles replaced the stainless steel and plastic versions in ICU rooms at three hospitals - Memorial Sloan-Kettering Cancer Center in New York City, the Medical University of South Carolina, and the Ralph H. Johnson VA Medical Center, both in Charleston, South Carolina. The first results, reported at the Atlanta conference, show that copper proved highly effective in reducing the total bacterial load in the rooms and on many of the objects in them. Also significantly, neither MRSA nor VRE were found on any of the sampled copper surfaces.
The recently-reported results from the Calama hospital trial in Chile also reached this conclusion, underlining copper's potential for reducing bioburden and therefore lowering the risk of infection.
|
